Acutus Medical, Inc. (NASDAQ: AFIB) reported Q2 EPS of ($0.93), $0.13 worse than the analyst estimate of ($0.80). Revenue for the quarter came in at $4.1 million versus the consensus estimate of $3.84 million.

For earnings history and earnings-related data on Acutus Medical, Inc. (AFIB) click here.